163 related articles for article (PubMed ID: 25640215)
21. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
22. [Brain metastases: Focal treatment (surgery and radiation therapy) and cognitive consequences].
Reygagne E; Du Boisgueheneuc F; Berger A
Bull Cancer; 2017 Apr; 104(4):344-355. PubMed ID: 28161072
[TBL] [Abstract][Full Text] [Related]
23. Management of patients with ≥4 brain metastases using stereotactic radiosurgery boost after whole brain irradiation.
Dincoglan F; Sager O; Gamsiz H; Uysal B; Demiral S; Oysul K; Sirin S; Caglan A; Beyzadeoglu M
Tumori; 2014; 100(3):302-6. PubMed ID: 25076242
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
[TBL] [Abstract][Full Text] [Related]
26. [Delineation of the surgical bed of operated brain metastases treated with adjuvant stereotactic irradiation: A review].
Keller A; Noël G; Antoni D
Cancer Radiother; 2017 Dec; 21(8):804-813. PubMed ID: 29170039
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique.
Kelly PJ; Lin YB; Yu AY; Alexander BM; Hacker F; Marcus KJ; Weiss SE
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):95-101. PubMed ID: 21168282
[TBL] [Abstract][Full Text] [Related]
28. [Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].
Patsouris A; Augereau P; Tanguy JY; Morel O; Menei P; Rousseau A; Paumier A
Cancer Radiother; 2014 Mar; 18(2):142-6. PubMed ID: 24433952
[TBL] [Abstract][Full Text] [Related]
29. Radiosurgery with flattening-filter-free techniques in the treatment of brain metastases : Plan comparison and early clinical evaluation.
Rieber J; Tonndorf-Martini E; Schramm O; Rhein B; Stefanowicz S; Kappes J; Hoffmann H; Lindel K; Debus J; Rieken S
Strahlenther Onkol; 2016 Nov; 192(11):789-796. PubMed ID: 27377261
[TBL] [Abstract][Full Text] [Related]
30. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
[TBL] [Abstract][Full Text] [Related]
32. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
33. [Reirradiation of brain metastasis: Review of the last five years].
Nguyen MN; Noel G; Antoni D
Cancer Radiother; 2019 Oct; 23(6-7):531-540. PubMed ID: 31447342
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
[TBL] [Abstract][Full Text] [Related]
35. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
[TBL] [Abstract][Full Text] [Related]
36. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
[TBL] [Abstract][Full Text] [Related]
37. Frameless stereotactic radiosurgery for brain metastases: a review of outcomes and prognostic scores evaluation.
Mok ST; Kam MK; Tsang WK; Poon DM; Loong HH; Yeung WM; Yeung TY; Yu J; Wong CK
Hong Kong Med J; 2017 Dec; 23(6):599-608. PubMed ID: 29125123
[TBL] [Abstract][Full Text] [Related]
38. Hippocampal sparing in stereotactic radiotherapy for brain metastases: To contour or not contour the hippocampus?
Di Carlo C; Trignani M; Caravatta L; Vinciguerra A; Augurio A; Perrotti F; Di Tommaso M; Nuzzo M; Giancaterino S; Falco MD; Genovesi D
Cancer Radiother; 2018 Apr; 22(2):120-125. PubMed ID: 29576492
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
